This study investigates the safety and efficacy of an investigational medication for treating blood clots in children. Blood clots, also known as venous thromboembolism (VTE), can be serious and require careful management. The investigational medication is being studied to see how well it works and how safe it is for children with these conditions.
In this study, participants will receive either the investigational medication or a standard treatment. The procedures will involve regular monitoring and assessments to track the effectiveness and safety of the treatment. A placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine, may be used in some cases.
- Who can participate: Children with a confirmed blood clot (VTE) who are planned to receive anticoagulation treatment for at least 12 weeks, or 6 weeks for neonates, may participate. Participants should not have received more than 7 days of anticoagulant treatment before joining the study.
- Study details: Participants will be involved in receiving either the investigational medication or a standard treatment, which may include a placebo. They will undergo regular assessments to monitor the safety and effectiveness of the treatment.
How understandable was the trial content above?
Hard to understand
Easy to understand
